Skip to content
Catalyst

PapersPMID:25358528

Role of lutein supplementation in the management of age-related macular degeneration: meta-analysis of randomized controlled trials.

Ophthalmic research2014The record ↗

  1. Finding, very limited evidenceraisesMacular pigment optical density

What moved

1 findingHow to read these marks →
  • “It has been found that lutein treatment was associated with a significant improvement in MPOD, with mean differences between lutein and placebo groups in the changes from baseline of 0.09 (95% CI: 0.06, 0.12; p < 0.00001).”
    Study
    meta-analysis
    Population
    AMD patients or individuals at risk of AMD

Study record

Design
meta-analysis
Species
human
Population
AMD patients or individuals at risk in five RCTs of lutein supplementation versus placebo
Participants
445
Comparator
placebo
Duration
not reported
Endpoints measured
3
Declined
another reason, stated per paper